Abstract
Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.
| Original language | English (US) |
|---|---|
| Title of host publication | Journal of Cardiovascular Medicine |
| Pages | 583-590 |
| Number of pages | 8 |
| Volume | 5 |
| Edition | 6 |
| State | Published - 1980 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
The new coronary vasodilators : calcium blockers. / Hillis, L. D.
Journal of Cardiovascular Medicine. Vol. 5 6. ed. 1980. p. 583-590.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - The new coronary vasodilators
T2 - calcium blockers
AU - Hillis, L. D.
PY - 1980
Y1 - 1980
N2 - Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.
AB - Considerable clinical promise is being shown by a group of investigational drugs that inhibit the movement of calcium into cells, thereby reducing both coronary and systemic vascular resistance and depressing myocardial contractility. In studies conducted here and abroad, calcium blockers appear to reduce the frequency of both typical and variant angina attacks and limit the extent and severity of myocardial injury in acute infarctions. Some of these agents also combat supraventricular tachyarrhythmias and reduce blood pressure in patients with systemic arterial hypertension.
UR - http://www.scopus.com/inward/record.url?scp=0019304854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019304854&partnerID=8YFLogxK
M3 - Chapter
AN - SCOPUS:0019304854
VL - 5
SP - 583
EP - 590
BT - Journal of Cardiovascular Medicine
ER -